Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A randomised, placebo controlled, double-blind, parallel group, international study to evaluate the safety and efficacy of rituximab (MabThera/Rituxan) in combination with methotrexate, compared to methotrexate monotherapy, in patients with active rheumatoid arthritis https://www.kusajili.fr:443/Trial/JeiuDnZEQU2Qu6vndy1P4g%24a-randomised-placebo-controlled-double-blind-parallel-group-international-study-to-evaluate-the-safety-and-efficacy-of-rituxima
I have read and accept the terms of use of the site and the Privacy Policy
Send your message